A recent study investigated the effects of the histone deacetylase (HDAC) inhibitors entinostat and vorinostat in AML cells and they observed that HDAC inhibitors upregulated the expression of genes that increased the intracellular labile iron pool [287]. The gene discussed is HDAC9; the disease is acute myeloid leukemia.